S. Udenfriend, B. Witkop, B. Redfield
Oct 1, 1958
Citations
0
Influential Citations
180
Citations
Quality indicators
Journal
Biochemical Pharmacology
Abstract
Abstract Harmaline and related compounds have been shown to be potent inhibitors of monoamine oxidase effecting 50 per cent inhibition of serotonin metabolism at 10−6 M. Inhibition is reversible both in vitro and in vivo. Procedures have been presented for evaluating the effectiveness of monoamine oxidase inhibitors bothin vitro and in vivo.